Xponance Inc. boosted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 59.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 41,073 shares of the company’s stock after buying an additional 15,241 shares during the period. Xponance Inc.’s holdings in HCA Healthcare were worth $8,491,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in HCA. JPMorgan Chase & Co. increased its position in shares of HCA Healthcare by 111.3% in the 1st quarter. JPMorgan Chase & Co. now owns 4,777,608 shares of the company’s stock valued at $899,815,000 after acquiring an additional 2,516,289 shares during the period. American Century Companies Inc. grew its position in HCA Healthcare by 1,066.6% during the 2nd quarter. American Century Companies Inc. now owns 644,926 shares of the company’s stock worth $133,332,000 after purchasing an additional 589,645 shares during the period. Amundi Asset Management US Inc. grew its position in HCA Healthcare by 101.4% during the 1st quarter. Amundi Asset Management US Inc. now owns 774,020 shares of the company’s stock worth $145,779,000 after purchasing an additional 389,617 shares during the period. Bank of New York Mellon Corp grew its position in shares of HCA Healthcare by 11.9% during the 1st quarter. Bank of New York Mellon Corp now owns 2,968,099 shares of the company’s stock valued at $559,011,000 after acquiring an additional 314,801 shares during the period. Finally, Deutsche Bank AG grew its position in shares of HCA Healthcare by 42.4% during the 2nd quarter. Deutsche Bank AG now owns 958,272 shares of the company’s stock valued at $198,112,000 after acquiring an additional 285,204 shares during the period. 68.57% of the stock is currently owned by hedge funds and other institutional investors.
NYSE:HCA opened at $256.33 on Friday. The company has a fifty day simple moving average of $250.16 and a two-hundred day simple moving average of $218.99. The company has a market cap of $82.06 billion, a price-to-earnings ratio of 17.58, a price-to-earnings-growth ratio of 1.38 and a beta of 1.65. The company has a quick ratio of 1.21, a current ratio of 1.45 and a debt-to-equity ratio of 18.06. HCA Healthcare, Inc. has a 52 week low of $115.74 and a 52 week high of $263.92.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 30th. Stockholders of record on Thursday, September 16th will be given a dividend of $0.48 per share. The ex-dividend date of this dividend is Wednesday, September 15th. This represents a $1.92 annualized dividend and a dividend yield of 0.75%. HCA Healthcare’s dividend payout ratio (DPR) is currently 16.54%.
A number of equities research analysts have recently commented on the company. BMO Capital Markets raised their target price on HCA Healthcare from $235.00 to $250.00 and gave the company a “market perform” rating in a research report on Wednesday, July 21st. Seaport Res Ptn reaffirmed a “buy” rating on shares of HCA Healthcare in a research note on Friday, July 9th. The Goldman Sachs Group raised their price target on shares of HCA Healthcare from $252.00 to $279.00 and gave the company a “buy” rating in a research note on Friday, August 6th. TheStreet lowered shares of HCA Healthcare from a “b” rating to a “c+” rating in a research note on Tuesday, July 20th. Finally, Cowen assumed coverage on shares of HCA Healthcare in a research note on Thursday, September 9th. They issued an “outperform” rating and a $293.00 target price on the stock. Five investment analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Buy” and a consensus target price of $246.76.
In other HCA Healthcare news, CMO Jonathan B. Perlin sold 40,000 shares of the company’s stock in a transaction dated Monday, August 2nd. The shares were sold at an average price of $250.00, for a total transaction of $10,000,000.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Charles J. Hall sold 3,000 shares of the company’s stock in a transaction dated Tuesday, July 27th. The stock was sold at an average price of $249.94, for a total transaction of $749,820.00. Following the transaction, the insider now owns 210,140 shares in the company, valued at $52,522,391.60. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 59,093 shares of company stock valued at $14,778,068. Corporate insiders own 1.60% of the company’s stock.
HCA Healthcare Company Profile
HCA Healthcare, Inc is a health care services company, which engages in operating hospitals, freestanding surgery centers and emergency rooms, and urgent care centers. It offers a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services.
Further Reading: What is the yield curve?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.